Canaery-Led Research Team Funded by US National Science Foundation Convergence Accelerator
UF Innovate | Accelerate resident client Canaery, the neurotech company revolutionizing the detection of important scents in real-world settings, announced it has secured $650,000 in Phase 1 funding from the U.S. National Science Foundation (NSF) Convergence Accelerator leading an interdisciplinary team of scientists, engineers, and operators. Teams that complete Phase 1 may qualify for up to $5 million in Phase 2 funding.
First Patient Enrolled in Rise Therapeutics’ Rheumatoid Arthritis Clinical Trial
Rise Therapeutics, a UF startup and a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, announced it has enrolled its first patient in its R-2487 Phase 1 rheumatoid arthritis clinical trial.
Global Food and Beverage Industry Representatives to Come to Orlando to Learn Latest Flavor Research
Flavor comes from a combination of nature and science. Food and beverage industry representatives from across the world will gather in Orlando in March to learn the research behind unique tastes and aromas.
Peak Strawberry Season Means More Florida-Grown, Flavorful Fruit at the Market
It's the height of the Florida strawberry harvesting season – a time when the state’s growers are doing all they can to make sure consumers can choose from among the best of their favorite fruit at the market.
Genetic Score Advances Personalized Treatment Strategies With Promising AML Drug
In the latest development in precision medicine approaches to treating pediatric leukemia, UF Health researchers have developed a genetic score to predict patient outcomes with a promising targeted drug treatment.
Study: UF Is World’s Top-Ranked Institution for Published Gene Therapy Research
The University of Florida is the world’s top contributor to scientific knowledge and literature about a widely used gene therapy technique, according to newly published research.
Scientists Train AI To Illuminate Drugs’ Impact on Cellular Targets
An ideal medicine for one person may prove ineffective or harmful for someone else, and predicting who could benefit from a given drug has been difficult. Now, an international team led by neuroscientist Kirill Martemyanov, Ph.D., based at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, is training artificial intelligence to assist.
Tech Tuesday: A Helpful Virus
In this week's Tech Tuesday for WCJB TV20, UF Innovate's Melanie Morón interviews Dr. Arun Srivastava from the University of Florida's College of Medicine Department of Pediatrics who introduces us to a virus -- the adeno-associated virus or AAV -- that cures rather than infects. AAV has cured nine human diseases. The FDA has approved five drugs using it. And Dr. Srivastava's lab of scientists is working to make the vectors more efficient.
UF Discovery Could Lead to Earlier Pancreatic Cancer Treatments
Pancreatic cancer’s stealth-like nature has the attention of University of Florida scientists, who have discovered a way to reverse a key cellular process involved in its progression.
UF Health Cancer Center Hosts 3rd Annual AI Day
The UF Health Cancer Center hosted its 3rd Annual AI Day in Cancer Research, drawing speakers and attendees from a range of disciplines, such as engineering, public health, data science, and radiology, to learn more about the role of AI in cancer research.
